Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02990767|
Recruitment Status : Unknown
Verified December 2016 by Shanghai First Maternity and Infant Hospital.
Recruitment status was: Recruiting
First Posted : December 13, 2016
Last Update Posted : December 13, 2016
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester|
|Study Start Date :||June 2016|
|Estimated Primary Completion Date :||June 2017|
|Estimated Study Completion Date :||June 2019|
collecting maternal factors, biophysical and biochemical markers at 11-13 weeks of gestation.
- Early preeclampsia [ Time Frame: 1 year ]
- Selective intrauterine fetal growth restriction [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02990767
|Contact: Luming Sun, PhDemail@example.com|
|Shanghai First Maternity and Infant Hospital||Recruiting|
|Shanghai, Shanghai, China, 200051|
|Contact: Luming Sun, PhD 021-20261151 firstname.lastname@example.org|